Clinical Trial Update: Predicting Outcome of Cytoreduction in Advanced Ovarian Cancer [NA]

View source ↗

Summary

This clinical trial entry indicates a recruiting study to predict the outcome of cytoreduction in advanced ovarian cancer (Stage III/Stage IV).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Ovarian Cancer Stage III, Ovarian Cancer Stage IV | NA | Status: RECRUITING